Abstract
Data on the management of male infertility secondary to hypogonadotrophic hypogonadism (HH) are limited. We report our extensive experience with intramuscular injections of gonadotropins, one of the two methods used for this purpose. Eighty-seven married men (median age, 28 years) with either congenital (47 men) or acquired (40 men) HH were treated for a median of 26 months (range, 6–57) with intramuscular injections of gonadotropins (HCG/HMG) three times weekly for the purpose of achieving fertility. The outcome was assessed by achievement of one or more pregnancies. Of the 151 courses of HCG/HMG treatment administered to 87 patients, 85 courses (56.3%) were successful, resulting in 85 pregnancies (median pregnancy rate 2, range 1–10) in 35 patients (40%) while 52 cases did not achieve pregnancy. Responders had larger pretherapy testicular volume (9 ± 3.6 cc) compared to non-responders [(5.7 ± 2.0 cc), P < 0.0001], but there was no difference in age, LH, FSH or testosterone levels or doses of HCG/HMG used. The pregnancy rate was similar in those with congenital (51.4%) and acquired causes (48.6%) of HH (P = 0.83). Only testicular size was predictive of conception (P < 0.001, odds ratio 1.5, 95% CI 1.21–1.92) while age, pretherapy levels of testosterone, LH, FSH and doses of HCG/HMG did not predict the success of pregnancy. Gonadotropins are moderately effective in achieving one to several pregnancies in HH. Only testicular size is predictive of success in achieving pregnancy. There is no difference in success between those with congenital and acquired causes of HH.
Similar content being viewed by others
References
Zitzmann M, Nieschlag E (2000) Hormone substitution in male hypogonadism. Mol Cell Endocrinol 161:73–88
Kliesch S, Behre HM, Nieschlag E (1994) High efficacy of gonadotropin or pulsatile gonadotropin-releasing hormone treatment in hypogonadotropic hypogonadal men. Eur J Endocrinol 131:347–354
Buchter D, Behre HM, Kliesch S et al (1998) Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur J Endocrinol 139:298–303
Liu L, Banks SM, Barnes KM et al (1988) Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 67:1140–1145
Finkel DM, Phillips JL, Snyder PJ (1985) Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 313:651–655
Burger HG, Baker HW (1984) Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann N Y Acad Sci 438:447–453
Burgues S, Calderon MD (1997) Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod 12:980–986
Liu PY, Gebski VJ, Turner L et al (2002) Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum Reprod 17:625–633
Bouloux PM, Nieschlag E, Burger HG et al (2003) Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J Androl 24:604–611
Miyagawa Y, Tsujimura A, Matsumiya K et al (2005) Outcome of gonadotropin therapy for male hypogonadotropic hypogonadism at university affiliated male infertility centers: a 30-year retrospective study. J Urol 173:2072–2075
Ishikawa T, Ooba T, Kondo Y et al (2007) Assessment of gonadotropin therapy in male hypogonadotropic hypogonadism. Fertil Steril 88:1697–1699
Pitteloud N, Hayes FJ, Dwyer A et al (2002) Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:4128–4136
Liu PY, Gordon Baker HW, Jayadev V et al (2008) Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin deficient infertile men: predictors of fertility outcome. J Clin Endocrinol Metab 94:801–808
Liu PY, Handelsman DJ (2003) The present and future state of hormonal treatment for male infertility. Hum Reprod Update 9:9–23
Delemarre-van de Waal HA (2004) Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism—diagnostic and therapeutic aspects. Eur J Endocrinol 151(Suppl 3):U89–94
Blumenfeld Z, Makler A, Frisch L et al (1988) Induction of spermatogenesis and fertility in hypogonadotropic azoospermic men by intravenous pulsatile gonadotropin-releasing hormone (GnRH). Gynecol Endocrinol 2:151–164
Spratt DI, Finkelstein JS, O’Dea LS et al (1986) Long-term administration of gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism. A model for studies of the hormone’s physiologic effects. Ann Intern Med 105:848–855
Crowley WF Jr, Filicori M, Spratt DI et al (1985) The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 41:473–531
Belchetz PE, Plant TM, Nakai Y et al (1978) Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 202:631–633
Liu PY, Swerdloff RS, Anawalt BD et al (2008) Determinants of the rate and extent of spermatogenic suppression during hormonal male contraception: an integrated analysis. J Clin Endocrinol Metab 93:1774–1783
Ley SB, Leonard JM (1985) Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens. J Clin Endocrinol Metab 61:746–752
Burris AS, Rodbard HW, Winters SJ et al (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J Clin Endocrinol Metab 66:1144–1151
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farhat, R., Al-zidjali, F. & Alzahrani, A.S. Outcome of gonadotropin therapy for male infertility due to hypogonadotrophic hypogonadism. Pituitary 13, 105–110 (2010). https://doi.org/10.1007/s11102-009-0203-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-009-0203-1